Table of Contents
Executive Summary — 6
SWOT
Analysis — 7
Indonesia Pharmaceutical And Healthcare
Industry SWOT — 7
Indonesia Political
SWOT — 8
Indonesia Economic SWOT — 9
Indonesia Business Environment SWOT — 10
Pharmaceutical
Business Environment Ranking — 11
Asia Pacific
Pharmaceutical Business Environment Ratings — 11
Limits of
Potential Returns — 12
Risks to Realisation of
Returns — 12
Indonesia – Market
Overview — 14
Regulatory Regime — 16
Intellectual Property Issues — 16
Generic Drug
Legislation — 18
Labelling
Requirements — 18
Counterfeit and Substandard
Drugs — 19
Free Trade Agreements — 20
Pricing Regime — 21
Reimbursement
Regime — 22
Price Cuts — 22
Industry
Trends and Developments — 24
Epidemiology — 24
Table: UN Millennium Development
Goals — 25
Avian Flu — 26
International Avian Flu Partnerships — 28
Healthcare
System — 29
Healthcare System
Reform — 30
International Healthcare
Collaborations — 31
Pharmaceutical
Sector — 32
Recent Pharmaceutical Industry
Developments — 34
Pharmaceutical Retail
Sector — 37
Research and
Development — 38
Herbal Medicines — 40
Medical Devices — 40
Table: Indonesia – Medical
Device Market Forecast — 42
Industry Forecast
Scenario — 43
Overall Market
Forecast — 43
Table: Indonesia – Drug Expenditure
Indicators, 2003-2013 — 44
Key Growth Factors –
Industry — 45
Table: Indonesia – Health Expenditure
Indicators, 2003-2013 — 46
Key Growth Factors –
Macroeconomic — 47
Table: Indonesia - Economic Activity,
2006-2013 — 49
Prescription Market
Forecasts — 50
Table: Indonesia – Prescription
Market Indicators, 2003-2013 (US$mn unless otherwise
stated) — 51
Patented Market
Forecast — 52
Table: Indonesia – Patented Drug
Market Indicators, 2003-2013 — 53
Generics Market
Forecast — 54
Table: Indonesia – Generic Drug
Market, 2003-2013 (IDRmn unless otherwise stated) — 55
OTC
Market Forecast — 56
Table: Indonesia – OTC Drug
Market, 2003-2013 — 57
Export/Import
Forecast — 58
Table: Indonesia – Pharmaceutical
Trade Indicators, 2003-2013 (US$mn) — 60
Medical Devices
Market Forecast — 61
Table: Indonesia – Medical
Device Market Indicators, 2004-2013 (US$mn unless otherwise
stated) — 61
Other Healthcare Data and
Forecasts — 62
Table: Indonesia – Other Health
Indicators, 2003-2013 — 62
Key Risks to BMI’s
Forecast Scenario — 63
Competitive
Landscape — 64
Company Profiles — 65
Leading Foreign Manufacturers — 65
Sanofi-Aventis — 65
Bayer — 67
Indigenous Manufacturers — 69
PT Kalbe
Farma — 69
PT Bio Farma — 74
Kimia
Pharma — 76
PT SidoMuncul — 79
Combiphar PT — 80
Country Snapshot: Indonesia Demographic
Data — 82
Section 1: Population — 82
Table: Demographic Indicators, 2005-2030 — 82
Table:
Rural/Urban Breakdown, 2005-2030 — 83
Section 2: Education
And Healthcare — 83
Table: Education,
2000-2005 — 83
Table: Vital Statistics,
2005-2030 — 83
Section 3: Labour Market And Spending
Power — 84
Table: Employment Indicators,
2001-2006 — 84
Table: Consumer Expenditure, 2000-2010
(US$) — 84
Table: Average Annual Manufacturing Wages,
2000-2012 (IDR) — 85
BMI Forecast
Modelling — 86
How We Generate Our Pharmaceutical Industry
Forecasts — 86
Pharmaceutical Business Environment Ratings
Methodology — 87
Ratings Overview — 87
Table: Pharmaceutical Business Environment Indicators — 88
Weighting — 89
Table: Weighting Of
Components — 89
Sources — 89
| 
View Cart
